iCBT for Depression - Standard Versus Condensed Treatment Material (KONRAD)

March 31, 2023 updated by: Fredrik Holländare, Örebro County Council

Internet-based Cognitive Behavior Therapy for Depression With Standard Treatment Material Compared to a Condensed Version

Internet-based cognitive behavior therapy (iCBT) has been shown effective for depression in several studies, however the investigators know very little about how the written treatment material should be designed to be effective and at the same time acceptable to the patients. The investigators are not aware of any research that has investigated if slow readers, or persons with difficulty concentrating, can use the standard material or if they would benefit more from using an adapted version.

In this study the investigators will assess reading speed and the ability to concentrate in all patients and then randomise them to an internet-based treatment for depression using either a standard material or a condensed one. The condensed material consists of 30000 words and will be available as text files and on audio files. The standard material consists of 60000 words and is only available as text files. Both groups will have the possibility of e-mail contact with a personal therapist during the treatment.

Patients will be recruited within Örebro County by referrals and self-referrals. The goal is to recruit between 200 and 300 patients during 2 years. The treatment time will be 10 weeks and all patients will be assessed for depression at an interview with a psychologist. There will also be interviews after treatment and one year after treatment. The most important outcome will be depressive symptoms.

Study Overview

Study Type

Interventional

Enrollment (Actual)

273

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Örebro County
      • Örebro, Örebro County, Sweden, 70116
        • Örebro County Council

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fullfill criteria for diagnosis of major depression
  • Being able to read and write Swedish
  • Have access to the internet
  • Being a resident in Örebro county

Exclusion Criteria:

  • Severe depressive symptoms (>34 on the MADRS-S)
  • High risk for suicide
  • Attending cognitive behavior therapy
  • Psychosis
  • Bipolar disorder
  • Addiction to alcohol or illegal drugs
  • A somatic or psychiatric condition that is a contraindication for iCBT or in some way debars iCBT, or have to be treated before depression

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard internet-based cognitive behavior therapy
Standard internet-based cognitive behavior therapy for depression with a written treatment material consisting of 60000 words (textmaterial only).
Introduction to CBT and depression, Behavioral activation, Cognitive restructuring, Improve sleep, Handeling anxiety, Relapse prevention
Other Names:
  • Standard iCBT
Experimental: Condensed internet-based cognitive behavior therapy
Condensed internet-based cognitive behavior therapy for depression with a written treatment material consisting of 30000 words (available as text or audio).
Introduction to CBT and depression, Behavioral activation, Cognitive restructuring, Improve sleep, Handeling anxiety, Relapse prevention
Other Names:
  • Condensed iCBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in depressive symptoms at post-treatment and after 12 months
Time Frame: At baseline, after 12 weeks, after 12 months
Depressive symptoms will be measured by the self-report measure Montgomery-Åsberg Depression Rating Scale- self-rated.
At baseline, after 12 weeks, after 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in diagnostic status for Major depression
Time Frame: Pre-treatment, after 12 weeks and after 1 year
The diagnostic status (depression) will be assessed in a face-to-face interview using the structured material Mini-International Neuropsychiatric Interview (M.I.N.I.).
Pre-treatment, after 12 weeks and after 1 year
Change from baseline in symptoms of anxiety
Time Frame: Pre-treatment, after 12 weeks and after 1 year
Symptoms of anxiety will be conducted using the self-report measure Beck Anxiety Inventory (BAI)
Pre-treatment, after 12 weeks and after 1 year
Post-treatment treatment satisfaction
Time Frame: After 12 weeks
Post-treatment treatment satisfaction will be measured by the self-report measure Client Satisfaction Questionnaire (CSQ)
After 12 weeks
Therapist time
Time Frame: Post treatment
Therapist time will be measured automatically by the IT-platform and assesses the time spent on each patient by each therapist. A mean time will be calculated to report an estimated time needed to treat one patient with the two interventions.
Post treatment
Alcohol use
Time Frame: Pre treatment
To assess alkolhol use the AUDIT-questionnaire will be filled out at pre treatment.
Pre treatment
Drug use
Time Frame: Pre treatment
To assess drug use the DUDIT-questionnaire will be filled out at pre treatment.
Pre treatment
Treatment satisfaction at follow up
Time Frame: After 1 year
Treatment satisfaction at follow up will be measured by the self-report measure Client Satisfaction Questionnaire (CSQ)
After 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reading speed
Time Frame: Pre treatment
To assess reading speed the "Diagnostiskt Läs och Skrivprov" (DLS) will be administered during the pre treatment interview.
Pre treatment
Ability to concentrate
Time Frame: Pre treatment
To assess the ability to concentrate six items from the WHO adult scale for attention deficit disorder (ASRS-VI.I) will be administered during the pre treatment interview.
Pre treatment
Change from baseline in risk for suicide
Time Frame: After 1,2,3,4,5,6,7,8,9,10,11,12 weeks
Change in risk for suicide will be measured by item 9 in the MADRS-S every week
After 1,2,3,4,5,6,7,8,9,10,11,12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Fredrik Holländare, PhD, Örebro County Council

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2013

Primary Completion (Actual)

December 3, 2017

Study Completion (Actual)

December 3, 2017

Study Registration Dates

First Submitted

February 1, 2013

First Submitted That Met QC Criteria

February 7, 2013

First Posted (Estimate)

February 11, 2013

Study Record Updates

Last Update Posted (Actual)

April 5, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 63:2012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Please contact us with suggestions for collaboration.

IPD Sharing Access Criteria

Upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • ANALYTIC_CODE

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depression

Clinical Trials on Standard internet-based cognitive behavior therapy

Subscribe